Translate
Entera Bio Ltd.
About
1.24USD-0.03 -2.36%
Closed • Updated at 12:52 GMT+00:00Market Cap$61.04M
Volume26.4K
Beta-0.70
RSI50.64
Entera Bio Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs
Apr 14 2026
Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613
Apr 2 2026
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
Mar 27 2026
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
Mar 4 2026
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis
Recent Videos
Entera Bio Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613
Apr 21, 2026
Entera Bio Virtual KOL Webinar - April 2026
Apr 20, 2026
Entera Bio's 8-K: My Take on New Partnerships & Leadership
Feb 05, 2026
Season 2, Episode 19: Confronting Osteoporosis with Miranda Toledano
Sep 29, 2025
Community Chat
Ask AI
Try asking